This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Sep 23;116(12):1999-2000.

doi: 10.1182/blood-2010-07-289900.

Targeting kinases in CML CLL

Varsha Gandhi¹

Affiliations

PMID: 20864583
DOI: 10.1182/blood-2010-07-289900

Free article

Comment

Targeting kinases in CML CLL

Varsha Gandhi. Blood. 2010.

Free article

. 2010 Sep 23;116(12):1999-2000.

doi: 10.1182/blood-2010-07-289900.

Author

Varsha Gandhi¹

Affiliation

¹ University of Texas M. D. Anderson Cancer Center, USA.

PMID: 20864583
DOI: 10.1182/blood-2010-07-289900

No abstract available

PubMed Disclaimer

Comment on

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals.
Herman SE, Gordon AL, Wagner AJ, Heerema NA, Zhao W, Flynn JM, Jones J, Andritsos L, Puri KD, Lannutti BJ, Giese NA, Zhang X, Wei L, Byrd JC, Johnson AJ. Herman SE, et al. Blood. 2010 Sep 23;116(12):2078-88. doi: 10.1182/blood-2010-02-271171. Epub 2010 Jun 3. Blood. 2010. PMID: 20522708 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems